ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, one of the nation’s largest and most innovative long-term care (LTC) pharmacy companies, and Guardian Pharmacy of the Heartland today announced the opening of a new pharmacy location in the greater Kansas City area. This pharmacy, located in Lenexa, Kansas, together with the Springfield and St. Louis, Missouri locations, will allow … [Read more…]
Partnership Provides Chinese Rightsholder with Access to New Markets While Offering Researchers Key Medical Science and Technology Content DANVERS, Mass.–(BUSINESS WIRE)–#Publishing—CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, has contracted with the Chinese Medical Association Publishing House (CMAPH) to offer document delivery and licensing solutions for all CMAPH journals. CMA titles will … [Read more…]
SWEDESBORO, N.J.–(BUSINESS WIRE)–#CompoundingPharmacy—Wedgewood Pharmacy has been named the American Animal Hospital Association’s (AAHA) preferred provider for compounding services. AAHA has more than 4,500 accredited veterinary practice and hospital members. It is the only exclusive North American companion-animal veterinary association, serving nearly 50,000 individual veterinary providers. It is the only organization that accredits veterinary practices in … [Read more…]
The Workforce Solutions Leader Wins Two Silver and One Bronze at the 43rd Annual Awards for Excellence in Video and Television BOCA RATON, Fla.–(BUSINESS WIRE)–Cross Country Healthcare, Inc., a market-leading workforce solutions tech-enabled talent platform and staffing, recruitment, and advisory firm, announced today it is the recipient of multiple Telly Awards for its best-in-class marketing … [Read more…]
ALBANY, N.Y.–(BUSINESS WIRE)–#AMRI–Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced the appointment of Niall Condon as president of its Manufacturing Division, with immediate effect. Condon will drive growth and be responsible for operational delivery of Curia’s commercial manufacturing services and products, including API and Drug Product. He will serve as … [Read more…]
Zone of potential insufficiency, where storage demand outstrips capacity, could be >25 zettabytes during 2030 Approximately 75% of all data stored to be ‘cold’ data, infrequently accessed ‘just in case’ it is needed Data retention times are ‘indefinite,’ say key industry executives, never deleted SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company … [Read more…]
WESTLAKE, Ohio–(BUSINESS WIRE)–Nordson Corporation (Nasdaq: NDSN) today announced it will release third quarter fiscal year 2022 earnings on August 22, 2022 after the close of the market. Nordson will host its quarterly webcast on Tuesday, August 23, 2022. Date: August 23, 2022 Time: 8:30 AM ET Listen via Internet: https://events.q4inc.com/attendee/942030981 Investors who are interested in … [Read more…]
NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that it has appointed Wendy K. Chung, M.D., Ph.D., to its Board of Directors. “Wendy is a tremendous addition to our Board of Directors. Her … [Read more…]
TAEUS® now protected by 53 patents issued globally, including 31 in the U.S. New U.S. patents expand potential licensing opportunities in data management ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent & Trademark Office has issued … [Read more…]
OT166 is a potential first-in-class non-invasive selective RGD integrin inhibitor, delivered as eye drop, for the treatment of diabetic retinopathy OT166 has the potential to address an unmet need for an earlier, non-invasive ophthalmic treatment for diabetic retinopathy BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases … [Read more…]
